中文名 | 4-硝基马尿酸 |
---|---|
英文名 | 2-[(4-nitrobenzoyl)amino]acetic acid |
中文别名 |
对硝基马尿酸
N-(4-硝基苯甲酰基)甘氨酸 |
英文别名 |
Hippuric acid,p-nitro
MFCD00007349 4-Nitrohippuric acid EINECS 220-156-5 p-nitrohippuric acid 4-nitro-hippuric acid p-Nitrobenzoylglycine |
描述 | N-(4-硝基苯甲酰)甘氨酸是甘氨酸(HY-Y0966)衍生物[1]。 |
---|---|
相关类别 | |
体外研究 | 氨基酸和氨基酸衍生物已被商业化用作能量补充剂。它们影响合成代谢激素的分泌、运动期间的燃料供应、压力相关任务期间的精神表现,并防止运动引起的肌肉损伤。它们被认为是有益的能生膳食物质[1]。 |
参考文献 |
密度 | 1.467g/cm3 |
---|---|
沸点 | 531.2ºC at 760mmHg |
熔点 | 131-133 °C(lit.) |
分子式 | C9H8N2O5 |
分子量 | 224.17000 |
闪点 | 275ºC |
精确质量 | 224.04300 |
PSA | 112.22000 |
LogP | 1.32330 |
蒸汽压 | 4.11E-12mmHg at 25°C |
储存条件 | 密封于阴凉干燥环境。 |
稳定性 | 如果遵照规格使用和储存则不会分解。 |
分子结构 | 1、 摩尔折射率:52.61 2、 摩尔体积(m3/mol):152.7 3、 等张比容(90.2K):437.4 4、 表面张力(dyne/cm):67.2 5、 极化率(10-24cm3):20.85 |
计算化学 | 1、 疏水参数计算参考值(XlogP):-0.4 2、 氢键供体数量:2 3、 氢键受体数量:5 4、 可旋转化学键数量:3 5、 拓扑分子极性表面积(TPSA):110 6、 重原子数量:16 7、 表面电荷:0 8、 复杂度:291 9、 同位素原子数量:0 10、 确定原子立构中心数量:0 11、 不确定原子立构中心数量:0 12、 确定化学键立构中心数量:0 13、 不确定化学键立构中心数量:0 14、 共价键单元数量:1 |
更多 | 1. 性状:无可用 2. 密度(g/mL,25/4℃):无可用 3. 相对蒸汽密度(g/mL,空气=1):无可用 4. 熔点(ºC):131-133 5. 沸点(ºC,常压):无可用 6. 沸点(ºC,5.2kPa):无可用 7. 折射率:无可用 8. 闪点(ºC):无可用 9. 比旋光度(º):无可用 10. 自燃点或引燃温度(ºC):无可用 11. 蒸气压(kPa,25ºC):无可用 12. 饱和蒸气压(kPa,60ºC):无可用 13. 燃烧热(KJ/mol):无可用 14. 临界温度(ºC):无可用 15. 临界压力(KPa):无可用 16. 油水(辛醇/水)分配系数的对数值:无可用 17. 爆炸上限(%,V/V):无可用 18. 爆炸下限(%,V/V): 无可用 19. 溶解性:无可用 |
Synonym:N-(4-Nitrobenzoyl)glycin Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
Risk Phrases: None Listed. Section 3 - HAZARDS IDENTIFICATION EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated. Potential Health Effects Eye: May cause eye irritation. Skin: May cause skin irritation. Ingestion: May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated. Inhalation: May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated. Chronic: No information found. Section 4 - FIRST AID MEASURES Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. Skin: Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: If victim is conscious and alert, give 2-4 cupfuls of milk or water. Get medical aid immediately. Inhalation: Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Notes to Physician: Section 5 - FIRE FIGHTING MEASURES General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing Media: Use water spray, dry chemical, carbon dioxide, or chemical foam. Section 6 - ACCIDENTAL RELEASE MEASURES General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - HANDLING and STORAGE Handling: Wash thoroughly after handling. Use with adequate ventilation. Minimize dust generation and accumulation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Storage: Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. Exposure Limits CAS# 2645-07-0: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - PHYSICAL AND CHEMICAL PROPERTIES Physical State: Solid Color: yellow Odor: Not available. pH: Not available. Vapor Pressure: Not available. Viscosity: Not available. Boiling Point: Not available. Freezing/Melting Point: 131 - 133 deg C Autoignition Temperature: Not available. Flash Point: Not available. Explosion Limits, lower: Not available. Explosion Limits, upper: Not available. Decomposition Temperature: Solubility in water: Specific Gravity/Density: Molecular Formula: C9H8N2O5 Molecular Weight: 224.17 Section 10 - STABILITY AND REACTIVITY Chemical Stability: Stable under normal temperatures and pressures. Conditions to Avoid: Dust generation. Incompatibilities with Other Materials: Strong oxidizing agents, strong bases. Hazardous Decomposition Products: Carbon monoxide, oxides of nitrogen, carbon dioxide. Hazardous Polymerization: Has not been reported. Section 11 - TOXICOLOGICAL INFORMATION RTECS#: CAS# 2645-07-0: MC0785000 LD50/LC50: Not available. Carcinogenicity: 4-Nitrohippuric acid - Not listed by ACGIH, IARC, or NTP. Other: See actual entry in RTECS for complete information. Section 12 - ECOLOGICAL INFORMATION Other No information available. Section 13 - DISPOSAL CONSIDERATIONS Dispose of in a manner consistent with federal, state, and local regulations. Section 14 - TRANSPORT INFORMATION IATA Not regulated as a hazardous material. IMO Not regulated as a hazardous material. RID/ADR Not regulated as a hazardous material. Section 15 - REGULATORY INFORMATION European/International Regulations European Labeling in Accordance with EC Directives Hazard Symbols: Not available. Risk Phrases: Safety Phrases: S 24/25 Avoid contact with skin and eyes. WGK (Water Danger/Protection) CAS# 2645-07-0: No information available. Canada None of the chemicals in this product are listed on the DSL/NDSL list. CAS# 2645-07-0 is not listed on Canada's Ingredient Disclosure List. US FEDERAL TSCA CAS# 2645-07-0 is not listed on the TSCA inventory. It is for research and development use only. SECTION 16 - ADDITIONAL INFORMATION N/A |
生态学数据: 该物质对环境可能有危害,对水体应给予特别注意。
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATAMUTATION DATA
|
WGK德国 | 3 |
---|---|
RTECS号 | MC0785000 |
海关编码 | 2924299090 |
~64% 2645-07-0 |
文献:F2G LTD Patent: WO2008/62182 A1, 2008 ; Location in patent: Page/Page column 153 ; |
~83% 2645-07-0 |
文献:Barati, Behjat; Moghadam, Majid; Rahmati, Abbas; Tangestaninejad, Shahram; Mirkhani, Valiollah; Mohammadpoor-Baltork, Iraj Synlett, 2013 , vol. 24, # 1 p. 90 - 96 |
~86% 2645-07-0 |
文献:Jursic; Neumann Synthetic Communications, 2001 , vol. 31, # 4 p. 555 - 564 |
~% 2645-07-0 |
文献:DeRuiter, Jack; Swearingen, Blake E.; Wandrekar, Vinay; Mayfield, Charles A. Journal of Medicinal Chemistry, 1989 , vol. 32, # 5 p. 1033 - 1038 |
~% 2645-07-0 |
文献:Curran, Terence C; Farrar, Charles R.; Niazy, Omima; Williams, Andrew Journal of the American Chemical Society, 1980 , vol. 102, # 22 p. 6828 - 6837 |
~% 2645-07-0 |
文献:Lebedukho; Kuritsyn; Sadovnikov Russian Journal of General Chemistry, 2004 , vol. 74, # 2 p. 222 - 224 |
~% 2645-07-0 |
文献:Um, Ik-Hwan; Chung, Eun-Kyung; Lee, So-Mi Canadian Journal of Chemistry, 1998 , vol. 76, # 6 p. 729 - 737 |
海关编码 | 2924299090 |
---|---|
中文概述 | 2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0% |
申报要素 | 品名, 成分含量, 用途, 包装 |
Summary | 2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |